血小板与动脉和静脉冠状动脉旁路血管的不同相互作用
Z H Yang1, P Stulz, L von Segesser
1Department of Research, University Hospital, Basel, Switzerland.
Lancet (London, England)
|April 20, 1991
概括
血小板与内部乳腺动脉和软静脉的相互作用不同. 血小板通过氧化在动脉中引起放松,但通过血栓素A2和血清素介导的静脉收缩.
科学领域:
- 心血管生物学 心血管生物学
- 血管生理学 血管生理学
- 血小板药理学 血小板药理学
背景情况:
- 血小板与血管壁的相互作用对心血管健康和疾病至关重要.
- 了解不同血管床中的这些相互作用是优化移植功能和治疗策略的关键.
研究的目的:
- 研究聚合血小板对人体内部乳腺动脉 (IMA) 和沙静脉 (SV) 段的差异效应.
- 阐明底层机制,包括内皮质,氧化,血栓素A2和血清素的作用.
主要方法:
- 在孤立的人体IMA和SV环中测量同度张力.
- 化学去除内皮质和特定途径 (ADPase,氧化合成酶,血栓和血清素受体) 的药理阻塞.
- 分析了对不同血小板度的度-反应曲线.
主要成果:
- 聚合血小板诱导了依赖内皮质的放松在诺拉丁上腺素合同的IMA中,由氧化释放介导.
- 相比之下,聚合血小板导致诺拉德林合同的SV进一步收缩,独立于氧化.
- 静止血管中的血小板诱导的收缩在内皮质的IMA中不存在,但在SV中存在并增强.
- 阿司匹林减少了收缩,但完全取消需要阻断静脉中的血栓素A2和血清素受体.
结论:
- 血小板衍生的ADP触发了IMA内皮的氧化释放,促进了放松.
- 血小板诱导的收缩中介于血小板甲基和血,突出了IMA和SV之间的差异机制.
- 这些血管特异性血小板反应可能解释了移植通透性和抗血小板药物疗效的差异.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...